US Venture Partners (USVP) is an early stage investment firm focusing in principally companies headquartered in the Western United States in three sectors of industry: medical, technology and retail/consumer.
DRI Capital manages private equity funds that purchase royalties from pharmaceutical and biotechnology companies, research institutions, universities, and inventors. DRI Capital is a pioneer and global leader in royalty investing with well over U.S. $2 billion in assets under management.
TVM Capital Life Science is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 30-years of transatlantic investment track record and in excess of US$1.4bn raised and under management.
The Accelerator Centre (AC) is dedicated to building and scaling sustainable, globally competitive technology firms; and to commercializing advanced research technologies emerging from academic institutions.